Skip to content
ppharmaranks
Menu

Decitabine: uses, dosing, side effects & brands

Decitabine is a medicine sold in the U.S. under 2 brand and generic names. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Available as
Injectable · Kit
Sold as
2 products — Dacogen and Decitabine
Prescription?
Prescription only
Generic available?
Yes

Every decitabine product we track (2)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Decitabine products
#DrugRatingPharmacy pays
1Not yet rated—View →
2Not yet rated—View →

Combination products containing decitabine

A combination is a different drug — different dosing, different warnings. It is listed here so you can find it, not so you can substitute it.

Decitabine recalls

From the FDA Enforcement database. A recall covers specific lots — not the drug as a whole.

How long decitabine keeps

The date on a sealed pack is not the only one: some decitabine labels start a second clock once the product is opened or mixed, as short as 4 hours.

The in-use limits decitabine labels print, quoted

What people report to the FDA about decitabine

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 5,466 reports naming decitabine, and the FDA flagged 96% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • febrile neutropenia557 reports
  • pneumonia434 reports
  • myelosuppression380 reports
  • neutropenia377 reports
  • pyrexia357 reports
  • platelet count decreased341 reports
  • fatigue325 reports
  • thrombocytopenia303 reports

Read these as a signal, not a rate. A report does not mean decitabine caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.

Source: openFDA drug/event (FAERS), retrieved September 25, 2026.

Related calculators

Frequently asked questions

Can you take decitabine with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run decitabine against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What brand names is decitabine sold under?

We track 2 decitabine-containing products in the U.S.: Dacogen and Decitabine. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

What forms does decitabine come in?

Across the brands we track, decitabine is currently marketed as injectable and kit, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic decitabine?

Yes. Our catalog lists 1 generic decitabine product alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

Has decitabine been recalled?

The FDA's Enforcement database lists 1 recall record whose product description mentions decitabine. The most recent: Decitabine for Injection 50mg per vial (Jul 2, 2024). A recall applies to specific lots, not to the drug as a whole — check the record for the affected lot numbers.

Cite this page
APA
pharmaranks. (2026, July 24). Decitabine: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/decitabine
MLA
“Decitabine: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/decitabine.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for decitabine on DailyMed (NIH) ↗.